Xiong H - Search Results

1

Phase II trial of combined irinotecan and oxaliplatin given every 3 weeks to patients with metastatic colorectal cancer.

Hoff PM, Wolff RA, Xiong H, Jones D, Lin E, Eng C, Dutta A, Bogaard KR, Abbruzzese JL. Hoff PM, et al. Among authors: xiong h. Cancer. 2006 May 15;106(10):2241-6. doi: 10.1002/cncr.21874. Cancer. 2006. PMID: 16598762 Free article. Clinical Trial.

2

A novel model system for studying the double-edged roles of nitric oxide production in pancreatic cancer growth and metastasis.

Wang B, Wei D, Crum VE, Richardson EL, Xiong HH, Luo Y, Huang S, Abbruzzese JL, Xie K. Wang B, et al. Among authors: xiong hh. Oncogene. 2003 Mar 27;22(12):1771-82. doi: 10.1038/sj.onc.1206386. Oncogene. 2003. PMID: 12660813

3

Yttrium 90 resin microspheres for the treatment of unresectable colorectal hepatic metastases after failure of multiple chemotherapy regimens: preliminary results.

Murthy R, Xiong H, Nunez R, Cohen AC, Barron B, Szklaruk J, Madoff DC, Gupta S, Wallace MJ, Ahrar K, Hicks ME. Murthy R, et al. Among authors: xiong h. J Vasc Interv Radiol. 2005 Jul;16(7):937-45. doi: 10.1097/01.RVI.0000161142.12822.66. J Vasc Interv Radiol. 2005. PMID: 16002501

4

Aggresome disruption: a novel strategy to enhance bortezomib-induced apoptosis in pancreatic cancer cells.

Nawrocki ST, Carew JS, Pino MS, Highshaw RA, Andtbacka RH, Dunner K Jr, Pal A, Bornmann WG, Chiao PJ, Huang P, Xiong H, Abbruzzese JL, McConkey DJ. Nawrocki ST, et al. Among authors: xiong h. Cancer Res. 2006 Apr 1;66(7):3773-81. doi: 10.1158/0008-5472.CAN-05-2961. Cancer Res. 2006. PMID: 16585204

5

Phase 1 study of TAS-102 administered once daily on a 5-day-per-week schedule in patients with solid tumors.

Overman MJ, Varadhachary G, Kopetz S, Thomas MB, Fukushima M, Kuwata K, Mita A, Wolff RA, Hoff PM, Xiong H, Abbruzzese JL. Overman MJ, et al. Among authors: xiong h. Invest New Drugs. 2008 Oct;26(5):445-54. doi: 10.1007/s10637-008-9142-3. Epub 2008 Jun 5. Invest New Drugs. 2008. PMID: 18528634 Clinical Trial.

6

Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head.

Varadhachary GR, Wolff RA, Crane CH, Sun CC, Lee JE, Pisters PW, Vauthey JN, Abdalla E, Wang H, Staerkel GA, Lee JH, Ross WA, Tamm EP, Bhosale PR, Krishnan S, Das P, Ho L, Xiong H, Abbruzzese JL, Evans DB. Varadhachary GR, et al. Among authors: xiong h. J Clin Oncol. 2008 Jul 20;26(21):3487-95. doi: 10.1200/JCO.2007.15.8642. J Clin Oncol. 2008. PMID: 18640929 Clinical Trial.

7

Phase I clinical study of three times a day oral administration of TAS-102 in patients with solid tumors.

Overman MJ, Kopetz S, Varadhachary G, Fukushima M, Kuwata K, Mita A, Wolff RA, Hoff P, Xiong H, Abbruzzese JL. Overman MJ, et al. Among authors: xiong h. Cancer Invest. 2008 Oct;26(8):794-9. doi: 10.1080/07357900802087242. Cancer Invest. 2008. PMID: 18798063 Clinical Trial.

8

Inhibition of the mammalian target of rapamycin (mTOR) in advanced pancreatic cancer: results of two phase II studies.

Javle MM, Shroff RT, Xiong H, Varadhachary GA, Fogelman D, Reddy SA, Davis D, Zhang Y, Wolff RA, Abbruzzese JL. Javle MM, et al. Among authors: xiong h. BMC Cancer. 2010 Jul 14;10:368. doi: 10.1186/1471-2407-10-368. BMC Cancer. 2010. PMID: 20630061 Free PMC article. Clinical Trial.

9

Bevacizumab plus gemcitabine and oxaliplatin as first-line therapy for metastatic or locally advanced pancreatic cancer: a phase II trial.

Fogelman D, Jafari M, Varadhachary GR, Xiong H, Bullock S, Ozer H, Lin E, Morris J, Cunningham P, Bennett B, Abbruzzese JL, Wolff RA. Fogelman D, et al. Among authors: xiong h. Cancer Chemother Pharmacol. 2011 Dec;68(6):1431-8. doi: 10.1007/s00280-011-1601-4. Epub 2011 Apr 9. Cancer Chemother Pharmacol. 2011. PMID: 21479635 Clinical Trial.

10

Phase II Randomized Trial of Sequential or Concurrent FOLFOXIRI-Bevacizumab Versus FOLFOX-Bevacizumab for Metastatic Colorectal Cancer (STEAM).

Hurwitz HI, Tan BR, Reeves JA, Xiong H, Somer B, Lenz HJ, Hochster HS, Scappaticci F, Palma JF, Price R, Lee JJ, Nicholas A, Sommer N, Bendell J. Hurwitz HI, et al. Among authors: xiong h. Oncologist. 2019 Jul;24(7):921-932. doi: 10.1634/theoncologist.2018-0344. Epub 2018 Dec 14. Oncologist. 2019. PMID: 30552157 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,262 results

Search Page

Filters